April 2018 Articles

ASCRS NEWS

  1. Crosslinking reimbursement

ASCRS • ASOA UPDATE

  1. ASCRS launches Young Eye Surgeons Learn and Earn Buy Down Program
  2. Ophthalmic community remembers Benjamin Boyd, MD
  3. Announcing the 2018 Resident Excellence Awards and research grants
  4. Multi-society task force releases specialty- specific guidelines for ophthalmic instrument cleaning and sterilization
  5. In the Journal of Cataract & Refractive Surgery April 2018

COVER FEATURE

  1. Considering premium IOLs for glaucoma patients
  2. Adopting MIGS into practice
  3. Making MIGS choices
  4. What’s coming in refractive surgery and MIGS?
  5. Monthly Pulse Intersection of refractive surgery and MIGS Poll size: 102

CATARACT

  1. Treating a cosmetic iris implant recipient
  2. Novel EDOF trifocal IOL may meet demands for improved intermediate vision
  3. Going from “pseudoexaphakia” to exaphakia
  4. Piggyback IOLs for the young eye surgeon

CORNEA

  1. Zeroing in on Xiidra
  2. Diagnosing Sjögren’s syndrome earlier

GLAUCOMA

  1. MIGS: Now that it’s here, who’s going to pay?
  2. Shielding neurons from harm

IN OTHER NEWS

  1. Ophthalmologist finds stress relief, fulfillment in making furniture

INTERNATIONAL

  1. TransPRK versus blunt alcohol-assisted PRK
  2. Studies show advances, value in OCT technology

NEWS & OPINION

  1. ASCRS plays significant role in recent advocacy victories for ophthalmology
  2. Interested in being part of these positive changes? Get off the sidelines and into the game today! How can you get involved?
  3. On the epiretinal edge
  4. Ocular HSV research yields new class of antiviral drugs that could have broad reach
  5. Of wizards and shamans

OPHTHALMOLOGY BUSINESS

  1. Help your administrator keep and earn life points
  2. Protecting your practice from cybersecurity threats

REFRACTIVE

  1. Technologies that improve refractive surgery
  2. Combining single step transepithelial PRK with accelerated CXL

RESIDENTS

  1. Topical NSAIDs in low risk cataract surgery patients lack a clear benefit to warrant changes in current practice patterns
  2. Intraindividual comparison of nepafenac 0.3% for the prevention of macular edema after phacoemulsification: Prospective randomized study
  3. A randomized controlled European multicentre trial on the prevention of cystoid macular edema after cataract surgery in non-diabetics: ESCRS PREMED study report 1

WORLD VIEW

  1. The evolving MIGS landscape